https://pharmadog.xyz/news/336683 pharmadog en 2026-08-28T17:59:54.000Z Legal scrutiny of Lindsay Clancy case may deter psychiatrists from treating mothers with mental illness https://pharmadog.xyz/news/336535 pharmadog en 2026-08-28T17:07:31.000Z BioNTech stops Phase 2 colorectal cancer mRNA vaccine trial after futility findings https://pharmadog.xyz/news/336447 pharmadog en 2026-08-28T15:59:00.000Z FDA clears updated COVID shots from Pfizer, Moderna and Novavax as Moderna raises $2.6 billion for cancer programs https://pharmadog.xyz/news/336387 pharmadog en 2026-08-28T15:28:48.000Z Phase 3 trial shows Wainua fails to improve outcomes in ATTR-CM, hazard ratio 1.14 https://pharmadog.xyz/news/336388 pharmadog en 2026-08-28T15:04:21.000Z BioXcel files for Chapter 11 bankruptcy, selling assets to Teva for up to $125 M https://pharmadog.xyz/news/336235 pharmadog en 2026-08-28T14:58:50.000Z Eli Lilly’s Mounjaro receives FDA approval to lower cardiovascular risk; Teva announces acquisition of approved drug https://pharmadog.xyz/news/336299 pharmadog en 2026-08-28T14:58:00.000Z AstraZeneca, Ionis data spark debate about RNA drugs’ impact on deadly heart disease https://pharmadog.xyz/news/336236 pharmadog en 2026-08-28T14:49:15.000Z BioNTech and Genentech halt Phase 2 trial of personalized mRNA cancer vaccine https://pharmadog.xyz/news/336279 pharmadog en 2026-08-28T14:34:39.000Z Erasca appoints Charles Fuchs, former Tubulis CMO, as president of research and development https://pharmadog.xyz/news/336237 pharmadog en 2026-08-28T14:30:23.000Z CRISPR Therapeutics to test highest dose of lipid‑lowering gene editing therapy after mixed durability data https://pharmadog.xyz/news/336301 pharmadog en 2026-08-28T14:30:00.000Z Biotech Index Surges as IPOs and M&A Activity Accelerate in 2026 https://pharmadog.xyz/news/336131 pharmadog en 2026-08-28T13:39:04.000Z AstraZeneca and Ionis report unexpected failure of heart disease drug in trial https://pharmadog.xyz/news/336111 pharmadog en 2026-08-28T13:30:51.000Z Eli Lilly's Mounjaro gets FDA approval to cut heart attack, stroke risk in type 2 diabetes https://pharmadog.xyz/news/336594 pharmadog en 2026-08-28T13:27:00.000Z BioNTech-Genentech halts colorectal cancer vaccine trial after higher death rate in vaccine arm https://pharmadog.xyz/news/336003 pharmadog en 2026-08-28T13:15:46.000Z Federal autism advisory panel reaffirms discredited theories amid vaccine controversy https://pharmadog.xyz/news/336023 pharmadog en 2026-08-28T13:12:00.000Z FDA approves Priovant's Lisraya (brepocitinib) for rare skin disease dermatomyositis https://pharmadog.xyz/news/336004 pharmadog en 2026-08-28T13:04:02.000Z FDA approves Roivant's new dermatomyositis therapy https://pharmadog.xyz/news/335983 pharmadog en 2026-08-28T13:00:37.000Z Genentech strikes second Asia deal in a week, betting up to $1B in oncology ADC alliance with DualityBio https://pharmadog.xyz/news/335984 pharmadog en 2026-08-28T12:10:39.000Z Priovant nabs first FDA approval for targeted tablet in dermatomyositis https://pharmadog.xyz/news/335791 pharmadog en 2026-08-28T11:30:02.000Z Roche commits over $1 billion to DualityBio for ADC development targeting TOP1 resistance https://pharmadog.xyz/news/335835 pharmadog en 2026-08-28T11:23:23.000Z AstraZeneca and Amgen’s Tezspire eyes Dupixent’s EoE stronghold after late-stage trial win https://pharmadog.xyz/news/335575 pharmadog en 2026-08-28T11:00:21.000Z Daiichi Sankyo to restructure its commercial organization, appointing Ken Keller as chief commercialization officer https://pharmadog.xyz/news/336318 pharmadog en 2026-08-28T10:30:00.000Z AusperBio adds $120M series C to advance hep B oligo therapy through phase 3 and beyond https://pharmadog.xyz/news/335471 pharmadog en 2026-08-28T10:15:29.000Z Cytokinetics reports positive pivotal trial results for aficamten in non-obstructive hypertrophic cardiomyopathy https://pharmadog.xyz/news/335407 pharmadog en 2026-08-28T09:45:14.000Z Cytokinetics aims for broader Myqorzo approval next year after supportive trial data https://pharmadog.xyz/news/335472 pharmadog en 2026-08-28T09:23:13.000Z AstraZeneca’s ATTR-CM Silencer Trial Fails to Show Benefit Over Existing Stabilizer Therapy https://pharmadog.xyz/news/336210 pharmadog en 2026-08-28T09:17:00.000Z Teva saddles up as stalking horse bidder for bankrupt BioXcel’s neuroscience portfolio https://pharmadog.xyz/news/335408 pharmadog en 2026-08-28T09:10:19.000Z AstraZeneca and Ionis gene silencer Wainua fails trial after patients also took Pfizer heart drug https://pharmadog.xyz/news/335345 pharmadog en 2026-08-28T08:30:00.000Z Former CDC leaders resign, warn of lingering political interference and call for stronger public health safeguards https://pharmadog.xyz/news/335344 pharmadog en 2026-08-28T08:30:00.000Z Medicare’s G2211 billing code for relationship-based primary care falls short of expectations https://pharmadog.xyz/news/335343 pharmadog en 2026-08-28T08:30:00.000Z Vaccine claims dominate federal autism advisory committee meeting, sidelining research funding plan https://pharmadog.xyz/news/335047 pharmadog en 2026-08-28T07:00:00.000Z Multispecific antibodies push CDMOs to redesign development platforms https://pharmadog.xyz/news/336427 pharmadog en 2026-08-28T04:00:00.000Z Early Alert: Angiographic Catheter Issue from Boston Scientific https://pharmadog.xyz/news/336703 pharmadog en 2026-08-28T04:00:00.000Z Early Alert: IV Start Kit Issue from Avid Medical https://pharmadog.xyz/news/334623 pharmadog en 2026-08-28T04:00:00.000Z CAR T therapy moves from cancer to autoimmune disease, leveraging oncology safety lessons https://pharmadog.xyz/news/335274 pharmadog en 2026-08-28T03:34:00.000Z Genentech pays $45M upfront to DualityBio for ADC platform targeting resistant cancers https://pharmadog.xyz/news/333811 pharmadog en 2026-08-27T22:14:58.000Z Gilead secures another FDA approval for HIV therapy, bolstering lenacapavir portfolio https://pharmadog.xyz/news/333643 pharmadog en 2026-08-27T21:27:19.000Z FDA approves Roivant's oral dermatomyositis drug Lisraya (brepocitinib) https://pharmadog.xyz/news/333431 pharmadog en 2026-08-27T19:47:01.000Z FDA approves Roivant's brepocitinib for rare autoimmune disease dermatomyositis https://pharmadog.xyz/news/333391 pharmadog en 2026-08-27T19:11:11.000Z FDA greenlights first oral therapy for adult dermatomyositis https://pharmadog.xyz/news/333259 pharmadog en 2026-08-27T18:41:54.000Z CMS GLP-1 pilot shows early uptake and health benefits for seniors, signaling broader weight-loss drug access https://pharmadog.xyz/news/333091 pharmadog en 2026-08-27T17:30:58.000Z Fifth Circuit Court rejects pharma industry's challenge to Medicare negotiation rules https://pharmadog.xyz/news/333155 pharmadog en 2026-08-27T17:27:49.000Z Former Stanford president posts emails to counter fraud claims in new book https://pharmadog.xyz/news/333156 pharmadog en 2026-08-27T17:21:14.000Z CMS to host launch event for ACCESS, its new Medicare chronic care pilot https://pharmadog.xyz/news/333115 pharmadog en 2026-08-27T16:55:38.000Z FDA grants emergency use authorization for generic Bimectin injection to prevent screwworm in cattle https://pharmadog.xyz/news/333047 pharmadog en 2026-08-27T16:32:00.000Z Outer Bio unveils skin‑tissue platform that keeps samples alive for a month, creating terabytes of data for skincare research https://pharmadog.xyz/news/332919 pharmadog en 2026-08-27T15:58:00.000Z AstraZeneca and Amgen report positive Phase 3 results for Tezspire in eosinophilic esophagitis https://pharmadog.xyz/news/332815 pharmadog en 2026-08-27T15:45:21.000Z Akeso CEO says biliary tract cancer data could be a breakthrough https://pharmadog.xyz/news/332920 pharmadog en 2026-08-27T15:30:00.000Z Revolution Medicines’ pancreatic cancer drug Rasonque priced at $39,800 a month, analysts predict blockbuster sales after swift FDA approval https://pharmadog.xyz/news/332879 pharmadog en 2026-08-27T15:26:50.000Z Hospitals Prepare Lobbying Effort to Counter $1 Trillion Health Care Funding Cuts https://pharmadog.xyz/news/332707 pharmadog en 2026-08-27T15:02:11.000Z Eli Lilly stops disclosing Phase 1 pipeline, prompting mixed reactions https://pharmadog.xyz/news/332708 pharmadog en 2026-08-27T14:59:41.000Z Moderna to raise $2 billion via convertible senior notes to fund oncology expansion and reduce debt https://pharmadog.xyz/news/332709 pharmadog en 2026-08-27T14:54:25.000Z Venture investor Redesign Health shifts from studio model to firm amid AI-driven startup boom https://pharmadog.xyz/news/332751 pharmadog en 2026-08-27T14:49:21.000Z Moderna raises $2 billion after Phase 3 success of its algorithm-driven personalized cancer vaccine with Merck https://pharmadog.xyz/news/332590 pharmadog en 2026-08-27T14:31:09.000Z Lonza appoints Samanta Cimitan as chief commercial officer as WuXi Biologics posts revenue surge https://pharmadog.xyz/news/336428 pharmadog en 2026-08-27T14:21:00.000Z B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container Due to the Presence of Particulate Matter https://pharmadog.xyz/news/332614 pharmadog en 2026-08-27T14:17:49.000Z Generate Bio drops as data accidentally leaked ahead of European conference https://pharmadog.xyz/news/335934 pharmadog en 2026-08-27T13:31:00.000Z Chutes & Ladders—Vivace revs up C-suite ahead of pivotal push https://pharmadog.xyz/news/332495 pharmadog en 2026-08-27T13:20:27.000Z FDA approves Revolution Medicines' first genetic-targeted therapy for advanced pancreatic cancer https://pharmadog.xyz/news/332496 pharmadog en 2026-08-27T13:16:38.000Z Documents show RFK Jr. sought to study Samoa’s MMR vaccines despite claiming his 2019 visit was unrelated to vaccines https://pharmadog.xyz/news/332367 pharmadog en 2026-08-27T13:01:06.000Z DEA moves on kratom substances as FDA greenlights new pancreatic drug https://pharmadog.xyz/news/332323 pharmadog en 2026-08-27T13:00:19.000Z Metriport secures $26 million Series A to streamline doctor access to patient data https://pharmadog.xyz/news/332368 pharmadog en 2026-08-27T13:00:00.000Z Senator Cassidy's report blames FDA for lax oversight of abortion pill manufacturers https://pharmadog.xyz/news/332219 pharmadog en 2026-08-27T11:39:35.000Z Revolution Medicines' Rasonge receives second-line pancreatic cancer nod, could drive $2.3B sales by 2028 https://pharmadog.xyz/news/332220 pharmadog en 2026-08-27T11:19:18.000Z AstraZeneca and Amgen’s Tezspire shows positive results in Phase 3 eosinophilic esophagitis trial https://pharmadog.xyz/news/332175 pharmadog en 2026-08-27T11:16:56.000Z Generate:Biomedicines shares early Phase 1 respiratory data after ERS poster leak https://pharmadog.xyz/news/332111 pharmadog en 2026-08-27T10:30:00.000Z Alnylam’s heart drug outlook dimmed as rival eplontersen fails at ESC Congress https://pharmadog.xyz/news/332565 pharmadog en 2026-08-27T10:10:00.000Z CEPI pledges up to $16.5M to advance Egyptian biotech's Ebola vaccine candidate https://pharmadog.xyz/news/332566 pharmadog en 2026-08-27T09:07:00.000Z Osivax licenses GC Biopharma seasonal flu vaccine to develop combined OVX836-GC FLU shot https://pharmadog.xyz/news/331835 pharmadog en 2026-08-27T08:30:00.000Z Moderna and Merck report late-stage success for personalized mRNA cancer vaccine https://pharmadog.xyz/news/331839 pharmadog en 2026-08-27T08:30:00.000Z Reddit reveals menopause symptoms often misdiagnosed, urging researchers to listen https://pharmadog.xyz/news/331837 pharmadog en 2026-08-27T08:30:00.000Z Hospitals Mobilize to Challenge $1 Trillion Medicaid Funding Cuts https://pharmadog.xyz/news/331838 pharmadog en 2026-08-27T08:30:00.000Z Proposed Biotech Investment National Security Act may protect US firms but contains loophole aiding Chinese competition https://pharmadog.xyz/news/331836 pharmadog en 2026-08-27T08:30:00.000Z Louisiana directs 20% of opioid settlement funds to sheriffs, who spend millions on police equipment https://pharmadog.xyz/news/331815 pharmadog en 2026-08-27T08:29:41.000Z Experts discuss hurdles and prospects for the first approved Fragile X therapy https://pharmadog.xyz/news/331540 pharmadog en 2026-08-27T07:00:00.000Z Biopharma hiring gaps: experts cite four key mismatches between companies and candidates https://pharmadog.xyz/news/331539 pharmadog en 2026-08-27T07:00:00.000Z Long-term unemployment pushes many biopharma professionals to quit job searches https://pharmadog.xyz/news/331391 pharmadog en 2026-08-27T06:00:00.000Z Scaling delivery is key for CAR T therapies to succeed in autoimmune diseases https://pharmadog.xyz/news/331263 pharmadog en 2026-08-27T04:07:00.000Z Obesity drug market surges as Lilly, Novo Nordisk lead and rivals chase $200B opportunity https://pharmadog.xyz/news/333175 pharmadog en 2026-08-27T04:00:00.000Z AVID Medical issues correction for convenience kits containing recalled Medline Namic Star Off-Handle manifolds https://pharmadog.xyz/news/333176 pharmadog en 2026-08-27T04:00:00.000Z Medtronic and Given Imaging issue early alert for Bravo CF esophageal pH capsule delivery devices due to attachment failures https://pharmadog.xyz/news/332298 pharmadog en 2026-08-27T03:22:00.000Z Roche receives expanded FDA clearance for HER2 diagnostic tests linked to Jazz’s Ziihera cancer drug https://pharmadog.xyz/news/334545 pharmadog en 2026-08-27T00:00:00.000Z FDA review highlights expanding role of manufacturing process models in drug applications https://pharmadog.xyz/news/334546 pharmadog en 2026-08-27T00:00:00.000Z MHRA revises guidance on periodic safety update reports for UK products https://pharmadog.xyz/news/334547 pharmadog en 2026-08-27T00:00:00.000Z FDA considers new deputy commissioner roles as Trump prepares to announce additional MFN drug pricing agreements